The Latest Breaking News from FDA

RSV rates — which tend to climb in the fall and winter months — are highest for children under the age of five.

Like many Americans struggling to lose weight, Marissa Montanino felt compelled to try Ozempic or one of the other new so-called "wonder drugs" described as revolutionary in the fight against obesity.

Eli Lily’s Zepbound will undercut its rivals’ pricing but still costs over $1,000 a month.

One common decongestant, phenylephrine, was found ineffective this fall. Doctors are skeptical about the rest of the over-the-counter cold cures lineup.

Antiseizure drugs levetiracetam and clobazam can cause a serious hypersensitivity reaction called drug reactions with eosinophilia and systemic symptoms (DRESS), the FDA said.

Shares in Dutch medical device manufacturer Philips plunged Wednesday after the US Food and Drug Administration warned that its new machine to help patients sleep risked overheating.

The pharma industry’s long-term solid outlook is driven by steady demand for drugs due to the rising frequency of chronic conditions and growing geriatric population coupled with rapid technological innovations. Hence, quality pharma stocks, CytomX Therapeutics (CTMX), Eton Pharmaceuticals (ETON), and GSK (GSK), might be solid investments now for potential…

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are down -0.17%, and Dec Nasdaq 100 E-Mini futures (NQZ2 3) are down -0.20%. Stock index futures this morning are under pressure on negative carryover from a decline in the Euro Stoxx 50 to a 1-week low. European stocks fell back...

Drugmakers shift reliance from China to India, benefiting Indian CDMOs. Western pharma companies are seeking to limit reliance on Chinese contractors, leading to increased interest in Indian CDMOs.

Neptune's Fix, a product sold illegally with claims to improve brain function and treat conditions such as anxiety, depression, pain and opioid use disorder, contains a potentially dangerous substance called tianeptine.

The US reproductive health expert on being sued for $1m, and winning a top prize for her fight for free speech in the public interest